Skip to content

COMPARING EFFICACY OF TWO DIFFERENT DOSES OF FENTANYL FOR PREVENTING HYPERTENSION AND TACHYCARDIA WHILE GIVING GENERAL AENESTHESIA

PROSPECTIVE RANDOMIZED DOUBLE BLIND COMPARATIVE STUDY OF EVALUATING EFFICACY AND SAFETY OF TWO DIFFERENT DOSES OF FENTANYL FOR PREVENTION OF SYMPATHOMIMETIC RESPONSE TO LARYNGOSCOPY AND INTUBATION IN CONTROLLED HYPERTENSIVE PATIENTS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/031837
Enrollment
60
Registered
2021-03-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Intravenous injection of fentanyl as a premedication: Evaluation of efficacy of Intravenous injection of fentanyl 2 mcg/kg or 3 mcg/kg to prevent pressure response of laryngoscopy and i

Sponsors

Government of Gujarat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Informed written consent. Patients posted for elective surgery under general Anesthesia requiring endotracheal intubation. ASA physical status || Well controlled primary idiopathic hypertension(blood pressure less then or equal to 140/90) with maximum three anti hypertensive medications excluding beta blockers. No end organ involvement due to hypertension. BMI less then or equal to 25. Modified Mallampati classification | and ||.

Exclusion criteria

Exclusion criteria: Patient refusing for consent. Patients with diabetes, COPD, renal disease, cardiac diseases like IHD, valvular heart disease, AV conduction block, aortic stenosis, left ventricular failure etc. Patient on drugs(sedatives,opioids,anti-psychotic drugs and beta blockers). Anticipated difficult intubation. BMI more then or equal to 25. Intubation attempt lasting longer than 15 seconds. Patient on more than 3 anti hypertensive medications. Defaulter of taking anti hypertensive medications as per schedule.

Design outcomes

Primary

MeasureTime frame
Variation in heart rate, systolic blood pressure, diastolic blood pressure, ST-T changes, cardiac rhythm changesTimepoint: From injection of intravenous fentanyl to 20 minutes after endotracheal intubation

Secondary

MeasureTime frame
To asses sedative effect of fentanyl and to observe any complicationsTimepoint: From injection of intravenous fentanyl to 60 minutes after endotracheal extubation

Countries

India

Contacts

Public ContactDr Dipshikha tripathi

B.J.medical college

drtripathi1961@yahoo.co.in9428408718

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026